NanoenTek (XKRX:039860) ROCE % : 19.32% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is NanoenTek ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NanoenTek's annualized ROCE % for the quarter that ended in Dec. 2024 was 19.32%.

NanoenTek ROCE % Historical Data

The historical data trend for NanoenTek's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoenTek ROCE % Chart

NanoenTek Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

4.64

10.62

9.74

-2.11

5.79

NanoenTek Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															13.43	-0.61	0.10	1.26	19.32

NanoenTek ROCE % Calculation

NanoenTek's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	3729.259	/	( ( (58578.3 - 4241.975)	+	(79006.526 - 4462.27) )	/ 2 )
	=	3729.259	/	( (54336.325	+	74544.256)	/ 2 )
	=	3729.259	/	64440.2905
	=	5.79 %

NanoenTek's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	14261.74	/	( ( (78628.453 - 5525.709)	+	(79006.526 - 4462.27) )	/ 2 )
	=	14261.74	/	( ( 73102.744	+	74544.256 )	/ 2 )
	=	14261.74	/	73823.5
	=	19.32 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

NanoenTek (XKRX:039860) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NanoenTek ROCE % Related Terms

Thank you for viewing the detailed overview of NanoenTek's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

NanoenTek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » NanoenTek Inc (XKRX:039860) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Ace Hi-end Tower, 235-2 Guro 3-dong, Guro-gu, Seoul, KOR, 152-740

Website

http://www.nanoentek.com

NanoenTek Inc is a South Korea-based company. It is engaged in the development and sale of life science experiment equipment, medical in-vitro diagnostic devices, point of care diagnostic devices, and related solutions. It provides live cell movie analyze products, including JuLI Br, a live cell movie analyzer; JuLI FL, a fluorescence live cell movie analyzer that enables users to perform image capturing and the time-lapse movie making; and JuLI Stage, a real-time cell history recorder for live cell imaging and analysis. The company also provides for the life science industry.

NanoenTek Headlines

No Headlines